AstraZeneca CEO says they've reduced emissions by 60%

AstraZeneca CEO says they've reduced emissions by 60%Подробнее

AstraZeneca CEO discusses oral weight loss drug agreement with EccogeneПодробнее

AstraZeneca CEO Soriot on Pharmaceuticals in ChinaПодробнее

We're in a difficult business but have the right level of confidence, says AstraZeneca CEOПодробнее

Tucker Carlson Explains Why He Launched The Nicotine Pouch, AlpПодробнее

AstraZeneca withdrawn worldwide over side effectsПодробнее

AstraZeneca Supports Trump's Drug-Rebate Overhaul, CEO SaysПодробнее

AstraZeneca is moving quickly with Covid antibody drug, CEO saysПодробнее

Pharma industry has a trust issue, AstraZeneca CEO says | CNBC ConversationПодробнее

AstraZeneca CEO Soriot Speaks on $6.9 Billion Cancer Therapy DealПодробнее

AstraZeneca 'within striking distance' of curing some cancers, CEO says | CNBC ConversationПодробнее

AstraZeneca to buy Alexion Pharmaceuticals in $39 billion dealПодробнее

AstraZeneca CEO: “Covid Is Here To Stay”Подробнее

Pharma CEOs testify before Senate committee on drug prices — 2/8/2024Подробнее

Recordati CEO sees 'substantial opportunity' in Sanofi drug purchaseПодробнее

CEO Pascal Soriot reflects on AstraZeneca's H1 2019 ResultsПодробнее

Pharmaceutical mogul says "That's our next VP of sales" after talk of bribing doctorsПодробнее

Engaging our entire value chain to reduce our Scope 3 emissionsПодробнее

AstraZeneca CEO: Objective is to replace chemotherapyПодробнее

AstraZeneca CEO on revenue beatПодробнее